Skip to Content

M MC2 (Mycophenolic acid delayed-release 360 mg)

Pill with imprint M MC2 is Orange, Capsule-shape and has been identified as Mycophenolic acid delayed-release 360 mg. It is supplied by Mylan Pharmaceuticals Inc..

Mycophenolic acid is used in the treatment of rejection prophylaxis; dermatomyositis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolic acid 360 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for M MC2

Mycophenolic acid delayed-release

Imprint:
M MC2
Strength:
360 mg
Color:
Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-4202

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide